definiens: means the costs associated with the manufacturing, purchasing, procurement andwarehousing of Trospium Twice - Daily, Trospium Once - Daily and Compound, as applicable, and with any other ProcessingActivities, that are actually incurred by Indevus ( provided that in all cases such amounts are not included in, and do not formthe basis of, any payments payable by [COMPANY] to Indevus pursuant to Section 6.2(c ) ), including ( a ) costs associated withprocuring active pharmaceutical ingredients and other materials used to manufacture Finished Products and/or Samples,(b ) the cost of transportation, testing, inspections, shrinkage and scrap, related taxes ( but in all cases excluding taxes basedupon income or receipts ), ( c ) the cost of storage, insurance and any subcontracted costs, and amounts payable to Third PartyManufacturers in connection with the manufacture and supply of Finished Products and/or Samples, including any fees relatedto minimum purchase requirements, ( d ) direct labor and, to the extent not in excess of ( i ) [ ... * * * ... ] for Trospium Once - Dailyand Trospium Twice - Daily through the Processing Assumption Date, provided the aggregate production Batches do notexceed [ ... * * * ... ] through the Processing Assumption Date, and ( ii ) [ ... * * * ... ] annually thereafter for Trospium Twice - Dailyprovided aggregate annual production Batches do not exceed [ ... * * * ... ] ( plus, solely with respect to this Section 1.87(d)(ii ), theincrease on [ ... * * * ... ] and each anniversary of such date in the Producer Price Index, Pharmaceutical Preparations ( Series ID325412325412 ) ( as published by the U.S. Bureau of Labor and Statistics ( http://www.bls.gov/ppi ) ) multiplied by such price),overhead costs, including an allocation for Indevus ’ internal costs and expenses for supply chain management, includingsupply chain production planning, the formulation and placement of orders with Third Party Manufacturers, the managementof inventories throughout the supply chain process, quality control / quality assurance, regulatory and Third PartyManufacturer oversight and cost accounting and including, with respect to Trospium Once - Daily Finished Product, and ( e ) anamount equal to the amounts payable by Indevus to Madaus pursuant to Section 3.7(b)(2 ) of theConfidential treatment has been requested for portions of this document . This copy of the document filed as an Exhibit omitsthe confidential information subject to the confidentiality request . Omissions are designated by the symbol [ ... * * * ... ] . Acomplete version of this document has been provided separately to the Securities and Exchange Commission